Area of research
Oncology · Epidemiology
Research interest
Research interests include Global Cancer Incidence and Screening, Colorectal Cancer Screening and Detection, Multiple and Secondary Primary Cancers, and Healthcare Systems and Practices.
General practitioners may improve cervical screening equality in France.
Evolution of the Incidence of Oral Cavity Cancers in the Elderly from 1990 to 2018.
Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice.
Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?
Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing
Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial
What is the most appropriate period to define synchronous cancers?
Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986-2015: The impact of overdiagnosis.
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
Epidemiology of rare cancers and inequalities in oncologic outcomes.
Treatment challenges in and outside a network setting: Head and neck cancers.
Treatment challenges in and outside a network setting: Soft tissue sarcomas.
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.
Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study
Survival of solid cancer patients in France, 1989–2013: a population-based study
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5
On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study
The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods
Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France
Le cancer de la prostate, évolution de l’incidence et de la mortalité en France entre 1980 et 2011
Total and partial cancer prevalence in the adult French population in 2008
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries
Breast cancer survival in the US and Europe: A CONCORD high‐resolution study
Cancer net survival on registry data: Use of the new unbiased Pohar‐Perme estimator and magnitude of the bias with the classical methods
Unbiased estimates of long‐term net survival of solid cancers in France